{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:16:35Z","timestamp":1787498195422,"version":"build-2736575974"},"reference-count":43,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T00:00:00Z","timestamp":1761436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["110\u2010A158"],"award-info":[{"award-number":["110\u2010A158"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["113\u2010X0027"],"award-info":[{"award-number":["113\u2010X0027"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Epilepsia Open"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Autoimmune mechanisms are a recognized cause of adult epilepsy, with immunotherapy offering etiology\u2010specific treatment. Autoimmune\u2010associated epilepsy is an emerging clinical entity, for which early diagnosis remains challenging and largely depends on neuronal antibody testing. This study investigates the utility of serum systemic autoantibodies as surrogate markers for positive neuronal antibodies and their potential in predicting epilepsy outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively enrolled adult epilepsy patients, excluding those with prior autoimmune diseases. All patients had baseline laboratory data, including ESR, ANA, and anti\u2010ENA. Further immunological evaluations included serum or CSF studies for systemic or neuronal autoantibodies. We compared the prevalence of systemic autoantibodies, seizure patterns, and EEG characteristics across immune, other, and unknown etiological groups and assessed epilepsy outcomes based on autoimmune comorbidities and systemic autoantibody presence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 333 patients (immune\u2009=\u200912, other\u2009=\u2009122, unknown\u2009=\u2009199), autoimmune\u2010associated epilepsy showed higher rates of status epilepticus (41.7% vs. 0.5% vs. 2.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), multifocal epileptogenicity (41.7% vs. 9.1% vs. 8.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), \u22652 anti\u2010seizure medications (83.3% vs. 28.6% vs. 43.4%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and a worse seizure outcome. Systemic autoantibodies were prevalent across subgroups (27.6%\u201341.7%), and autoimmune comorbidities were newly diagnosed in 5.5%\u20139.8% of cases, but no differences were observed across groups. The prevalence of antiphospholipid syndrome (2.1%) and Sj\u00f6gren's syndrome (1.5%) was high in our study cohort. Neither autoimmune comorbidities nor systemic autoantibodies correlated with seizure types, EEG patterns, seizure frequency, number of ASMs, or outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance<\/jats:title>\n                    <jats:p>Autoantibody testing contributes to unexpectedly high rates of new rheumatological diagnoses following epilepsy, often preceding systemic symptoms. However, systemic autoantibodies cannot reliably predict epilepsy characteristics or outcomes. Multifocal epileptogenicity on EEG and high seizure burden may be characteristic features in autoimmune\u2010associated epilepsy. These findings suggest that adult epilepsy patients should benefit from a tiered approach to immunological evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Plain Language Summary<\/jats:title>\n                    <jats:p>Autoimmune causes of epilepsy are increasingly recognized, and some patients may benefit from immunotherapy in addition to standard anti\u2010seizure drugs. We retrospectively analyzed adult epilepsy patients by underlying cause and examined their clinical features, EEG findings, and blood tests for systemic autoantibodies. In our study, although these systemic autoantibodies were prevalent, they did not help predict seizure type, EEG pattern, or treatment outcome. However, we found that patients with seizure activity coming from several parts of the brain or frequent, hard\u2010to\u2010control seizures may have autoimmune\u2010associated epilepsy and could benefit from advanced immune evaluation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/epi4.70159","type":"journal-article","created":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:40:37Z","timestamp":1761518437000},"page":"1905-1917","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Defining the role of systemic autoimmune markers in adult epilepsy: A focus on autoimmune\u2010associated epilepsy"],"prefix":"10.1002","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-639X","authenticated-orcid":false,"given":"I\u2010Ting","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Neurology National Taiwan University Hospital  Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiehyu","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine National Taiwan University Hospital  Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1375-048X","authenticated-orcid":false,"given":"Chi\u2010Ting","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Neurology National Taiwan University Hospital  Taipei Taiwan"},{"name":"Department of Neurology En Chu Kong Hospital  New Taipei City Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang\u2010Yu Edward","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Neurology National Taiwan University Hospital  Taipei Taiwan"},{"name":"Department of Neurology National Taiwan University Hospital, Hsin\u2010Chu Branch  Hsinchu Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin\u2010Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology National Taiwan University Hospital  Taipei Taiwan"},{"name":"Epilepsy Center, National Taiwan University Hospital  Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tun","family":"Jao","sequence":"additional","affiliation":[{"name":"Department of Neurology National Taiwan University Hospital  Taipei Taiwan"},{"name":"Epilepsy Center, National Taiwan University Hospital  Taipei Taiwan"},{"name":"Department of Neurology National Taiwan University  Taipei Taiwan"},{"name":"CERVO Brain Research Centre, Laval University  Qu\u00e9bec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,10,26]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00038-3"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011839"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02522.x"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13709"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.16571"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2024.05.017"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17478"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14649"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.188"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa362"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2019.12.015"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12550"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-025-01089-4"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.18338"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNP.0000000000000806"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400909"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2020.10.019"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurop.2023.100144"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17245"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200225"},{"issue":"23","key":"e_1_2_10_23_1","first-page":"S4","article-title":"False positive cerebrospinal fluid NMDA receptor antibodies: a single center case series","volume":"99","author":"Ardakani R","year":"2022","journal-title":"Neurology"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-008-0028-1"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002665"},{"issue":"10","key":"e_1_2_10_26_1","article-title":"The presence of extractable nuclear antigens (ENA) antibodies in a large population\u2011based cohort from the Netherlands and their association with known risk factors for systemic lupus erythematosus and primary Sj\u00f6gren syndrome [abstract]","volume":"71","author":"Yntema\u2010Eckenhaussen P","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.10.007"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e5841"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.6530"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2019.10.042"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.5.388"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109803"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00521"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2009.0205"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-01038-2"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-022-00409-8"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.06.001"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1020709"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1159\/000121423"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2018.11.012"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.2315"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.47"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.13103"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00401-9"}],"container-title":["Epilepsia Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/epi4.70159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:27:07Z","timestamp":1766161627000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/epi4.70159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,26]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1002\/epi4.70159"],"URL":"https:\/\/doi.org\/10.1002\/epi4.70159","archive":["Portico"],"relation":{},"ISSN":["2470-9239","2470-9239"],"issn-type":[{"value":"2470-9239","type":"print"},{"value":"2470-9239","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,26]]},"assertion":[{"value":"2025-04-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}